G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2001
11/29/2001	WO2001090362A1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof
11/29/2001	WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090354A1 Treatment of cancer and neurological diseases
11/29/2001	WO2001090353A1 A process for determining the tumoricidal potential of a sample by the use of a nucleic acid which is downregulated in human tumor cells
11/29/2001	WO2001090347A1 Antiviral antisense therapy
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001	WO2001090312A1 Ammonia-oxidizing bacteria
11/29/2001	WO2001090304A2 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001090253A1 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
11/29/2001	WO2001090228A1 Molecular imprinting
11/29/2001	WO2001090196A1 Immunoassay method for x-type phospholipase a¿2?
11/29/2001	WO2001090195A1 Immunoassay method for x-type phospholipase a¿2?
11/29/2001	WO2001090194A2 Antibodies against particular forms of propsa and use thereof in immunoassays
11/29/2001	WO2001090191A2 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS
11/29/2001	WO2001090189A2 G-protein coupled receptor org3.
11/29/2001	WO2001090188A2 Receptor-based interaction trap
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090163A2 Use of the gabab receptor in assays to identify gamma hydroxybutyrate agonists, antagonists, and allosteric modulators of agonists
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090153A2 Reagents for cell selection and methods of use
11/29/2001	WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090147A2 Long wavelength engineered fluorescent proteins
11/29/2001	WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
11/29/2001	WO2001089788A2 Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks
11/29/2001	WO2001089699A1 Improvements to microcontainers for clinical assays
11/29/2001	WO2001089696A2 Microfluidic concentration gradient loop
11/29/2001	WO2001089692A2 Nucleic acid amplification and detection using microfluidic diffusion based structures
11/29/2001	WO2001089682A2 Device and method for addressing a microfluidic cartridge
11/29/2001	WO2001089675A2 Jet vortex mixer
11/29/2001	WO2001089585A1 tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES
11/29/2001	WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001	WO2001089565A1 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
11/29/2001	WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089531A1 Crystal structures of p- selectin,ep0105895-selectin complexes, and uses thereof
11/29/2001	WO2001089449A2 Phospholipase d effectors for therapy and screening
11/29/2001	WO2001089361A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
11/29/2001	WO2001089298A2 Compositions and methods of nematode control
11/29/2001	WO2001062284A3 Novel method for down-regulation of amyloid
11/29/2001	WO2001046694A3 A bioluminescence resonance energy transfer (bret) fusion molecule and method of use
11/29/2001	WO2001044280A3 Methods and compositions for the manufacture of replication incompetent adenovirus
11/29/2001	WO2001043869A3 Cell arrays and the uses thereof
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040293A3 Method of modulating proapoptotic and antiapoptotic pathways in cells
11/29/2001	WO2001040278A3 Human semaphorin zsmf-16
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001035096A3 Diseases associated with altered mitochondrial function
11/29/2001	WO2001034806A3 Methods and compositions for screening using diphtheria toxin constructs
11/29/2001	WO2001033217A3 Monitoring the activity of factor xa inhibitors
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001029264A3 Nucleic acid primers and probes for detecting tumor cells
11/29/2001	WO2001025471A3 Method for the detection of antimicrobial residues
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023590A3 22196, a novel human aminopeptidase
11/29/2001	WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/29/2001	WO2001006257A8 Metal nanoshells for biosensing applications
11/29/2001	WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors
11/29/2001	WO2000073469A3 Protein kinases
11/29/2001	WO2000061597A9 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
11/29/2001	WO2000047104A9 Antagonists of hmg1 for treating inflammatory conditions
11/29/2001	WO2000040722A3 Insulin-synthesis genes
11/29/2001	US20010047526 Mapping molecular interactions in plants with protein fragments complementation assays
11/29/2001	US20010047252 Disease simulation system and method
11/29/2001	US20010047128 Method for non-invasive spectrophotometric blood oxygenation monitoring
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010047080 Inhibits hiv infection of cells
11/29/2001	US20010047078 Methods for identifying inhibitors of methionine aminopeptidases
11/29/2001	US20010047077 Nucleic acid analogs with a chelating functionality
11/29/2001	US20010047035 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (NO) in specimens taken from the patient under controlled conditions
11/29/2001	US20010046714 Table for binding components of a sample, such as nucleic acids, comprising magnetic particles and an excipient that links the particles; useful in analysis of liquids
11/29/2001	US20010046713 Detecting autoantibody reactivity with Thomsen-Friedenreich antigen; increased levels are indicative oof endometriosis
11/29/2001	US20010046709 Colloid of brilliant blue dye in dilute acid, especially mineral acid; staining and destaining immobilized protein
11/29/2001	US20010046708 Leukocytes, lytic agent (e.g., alkanoic acid), quench, and post-lytic fixing agent (e.g., propylene glycol)
11/29/2001	US20010046706 Controlled electroporation and mass transfer across cell membranes
11/29/2001	US20010046702 Devices for performing array hybridization assays and methods of using the same
11/29/2001	US20010046701 Nucleic acid amplification and detection using microfluidic diffusion based structures
11/29/2001	US20010046700 Fluid control module and temperature controller
11/29/2001	US20010046688 Substrate of an oxidant, stabilizer and buffer with an extended shelf life is useful with enzyme based probes; detecting DNA fragments in DNA sequencing
11/29/2001	US20010046687 Stabilized by adding trehalose to its saturation solubility; microorganism detection for cleanliness of food preparation areas
11/29/2001	US20010046686 Early detetion, prognosis, monitoring and evaluation of response to cancer and other disease therapies
11/29/2001	US20010046685 Aqueous medium and reagents for assessing fibrinogen biological activity and activity of the reagent for determining platelet count
11/29/2001	US20010046684 Methods of structure-based drug design using MS/MNR
11/29/2001	US20010046683 Simultaneous processing of plural test samples; no immobilization of receptor required
11/29/2001	US20010046682 Presence of a target reactant is determined by measuring the amount of material bound to an immobilized reactant
11/29/2001	US20010046678 Dissociating a solution of double stranded nucleic acid into single strands to measure UV absorption and acquiring a thermal melting profile
11/29/2001	US20010046676 Integrated sequencing device
11/29/2001	US20010046675 Method and apparatus for producing biochips
11/29/2001	US20010046674 Upon binding a ligand to a signal generated by a reporter molecule, detecting and quantifying the ligand in solution
11/29/2001	US20010046671 Hybridizing gene sequences from biological processes with probes and determining and identifying genes that are differentially expressed; contains only gene sequences of interest in a particular area
11/29/2001	US20010046670 Single stranded DNA sequence hybridizes an oligonucleotide or DNA analogue and then complexes with a marker; output signals are measured for formation and dissociation indications
11/29/2001	US20010046667 Determination of latent HIV infection
11/29/2001	US20010046666 Angiogenesis assay
11/29/2001	US20010046665 Method of identifying the function of a test agent
11/29/2001	US20010046664 Detecting the signal of a calcium indicator in a sample of cytosol, mitochondrion and a calcium cation source, and comparing in the absence and presence of test agents
11/29/2001	US20010046663 A compound is attached to a solid support and enzyme binding is assessed with/without the presence of metal; modulation detection

1 ... 2904 2905 2906 2907 2908 2909 2910 2911 2912 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 ... 3937